These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25603456)

  • 21. Effects of tibolone and its metabolites on prolactin and insulin-like growth factor binding protein-1 expression in human endometrial stromal cells.
    Guzel E; Buchwalder L; Basar M; Kayisli U; Ocak N; Bozkurt I; Lockwood CJ; Schatz F
    Gynecol Endocrinol; 2015 May; 31(5):414-8. PubMed ID: 25856298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tibolone exerts progestational inhibition of matrix metalloproteinase expression in human endometrial stromal cells.
    Schatz F; Kuczynski E; Kloosterbooer L; Krikun G; Buchwalder LF; Rahman M; Lockwood CJ
    Steroids; 2006 Sep; 71(9):768-75. PubMed ID: 16806336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
    Mirkin S; Archer DF
    Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy.
    Nahas-Neto J; Luca LA; Griva BL; Morceli J; Nahas EA; Moriguchi SM; Uemura G; Traiman P
    Maturitas; 2006 Jan; 53(1):97-106. PubMed ID: 15941630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differential effects on serum IGF-1 of tibolone (5 mg/day) vs combined continuous estrogen/progestagen in post menopausal women].
    Porcile A; Gallardo E; Duarte P; Aedo S
    Rev Med Chil; 2003 Oct; 131(10):1151-6. PubMed ID: 14692305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tibolone on estrogen biosynthesis in the mammary tissue of postmenopausal monkeys.
    Stute P; Register TC; Blair RM; Cline JM
    Menopause; 2006; 13(2):232-40. PubMed ID: 16645537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progestin effects on cell proliferation pathways in the postmenopausal mammary gland.
    Wood CE; Branstetter D; Jacob AP; Cline JM; Register TC; Rohrbach K; Huang LY; Borgerink H; Dougall WC
    Breast Cancer Res; 2013; 15(4):R62. PubMed ID: 23938070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tibolone].
    Jamin C; Poncelet C; Madelenat P
    Presse Med; 2002 Sep; 31(28):1314-22. PubMed ID: 12355994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
    Bisanti T; Cavalieri AP; Capri O; Galoppi P; De Felice C; Porfiri LM; Perrone G
    Minerva Ginecol; 2004 Apr; 56(2):125-30. PubMed ID: 15258540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment.
    Conner P; Christow A; Kersemaekers W; Söderqvist G; Skoog L; Carlström K; Tani E; Mol-Arts M; von Schoultz B
    Climacteric; 2004 Mar; 7(1):50-8. PubMed ID: 15259283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML; van de Weijer P; Franke HR; Pornel B; von Mauw EM; Nijland EA;
    BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen and progestogen inhibit NF-κB in atherosclerotic tissues of ovariectomized ApoE (-/-) mice.
    Chen Y; Zhao H; Ren X
    Climacteric; 2016 Aug; 19(4):357-63. PubMed ID: 27138353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
    Dahm AE; Eilertsen AL; Goeman J; Olstad OK; Ovstebø R; Kierulf P; Mowinckel MC; Skretting G; Sandset PM
    Thromb Res; 2012 Jul; 130(1):45-51. PubMed ID: 22217510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tibolone on bone quality in ovariectomized monkeys.
    Lees CJ; Ederveen AG; Spanjers CP; Clarkson TB
    Menopause; 2005; 12(5):613-8. PubMed ID: 16145316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen.
    Klaassens AH; van Wijk FH; Hanifi-Moghaddam P; Sijmons B; Ewing PC; Ten Kate-Booij MJ; Kooi GS; Kloosterboer HJ; Blok LJ; Burger CW
    Fertil Steril; 2006 Aug; 86(2):352-61. PubMed ID: 16828477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
    Ederveen AG; Kloosterboer HJ
    J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of estrogen in the formation and development of abdominal aortic aneurysm: experiment with rats].
    Wu XF; Zhang J; Xin SJ; Duan ZQ; Zhang G
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):471-4. PubMed ID: 17459227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
    Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro effects of tibolone and its metabolites on human vascular coronary cells.
    Seeger H; Kloosterboer HJ; Studen M; Wallwiener D; Mueck AO
    Maturitas; 2007 Sep; 58(1):42-9. PubMed ID: 17572028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.